Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A
GermanyStudy on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients
GermanyStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
GermanyStudy on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer
GermanyGermanyStudy on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth
GermanyStudy on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes
GermanyStudy on Treating Status Epilepticus in Seniors Using Levetiracetam and Valproate Semisodium
GermanyStudy of Personalized Peptide Vaccine with PERVI-FUS, PERVI-NEO, and 11902A for Children and Young Adults with Metastatic Fusion-Driven Sarcomas
GermanyStudy on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis
GermanyStudy on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy
GermanyStudy Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
